Ensign Peak Advisors
CORZ icon

Ensign Peak Advisors’s Core Scientific CORZ Stock Holding History

Ensign Peak Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Sell
15,150
-850
-5% -$20K ﹤0.01% 1074
2026
Q1 		$239K Hold
16,000
– – ﹤0.01% 1232
2025
Q4 		$233K Buy
+16,000
New +$279K ﹤0.01% 1238
2025
Q3 		– Sell
-64,100
Closed -$1.09M – 1702
2025
Q2 		$1.09M Hold
64,100
– – ﹤0.01% 1194
2025
Q1 		$464K Buy
64,100
+1,650
+3% +$18.8K ﹤0.01% 1569
2024
Q4 		$877K Buy
+62,450
New +$923K ﹤0.01% 1399

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Ensign Peak Advisors's CORZ Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Core Scientific (CORZ) stake by 5.3% in Q2 2026, selling an estimated $20K and leaving 15,150 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Ensign Peak Advisors first reported a position in CORZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.09M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Ensign Peak Advisors held 15,150 shares of Core Scientific worth $388K as of Q2 2026.
  • Ensign Peak Advisors sold 850 Core Scientific shares in Q2 2026, an estimated $20K.
  • Core Scientific made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1074 holding.
  • Ensign Peak Advisors first reported a position in Core Scientific in Q4 2024 and has held it in 6 quarters since.
  • Ensign Peak Advisors's Core Scientific position peaked at $1.09M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.